metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of...
Información de la revista
Vol. 14. Núm. 1.
Páginas 7-19 (enero - febrero 2015)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
5225
Vol. 14. Núm. 1.
Páginas 7-19 (enero - febrero 2015)
Open Access
Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases
Visitas
5225
Rolf Teschke
,
Autor para correspondencia
rolf.teschke@gmx.de

Correspondence and reprint request:
, Li Zhang, Hongzhu Long, Alexander Schwarzenboeck*, Wolfgang Schmidt-Taenzer*, Alexander Genthner*, Albrecht Wolff§, Christian Frenzel, Johannes Schulze, Axel Eickhoff*
* Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Teaching Hospital of the Medical Faculty of the Goethe University Frankfurt/ Main, Germany
Center for Drug Reevaluation, China Food and Drug Administration, Beijing, China
Department of Internal Medicine, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China
§ Department of Internal Medicine II, Division of Gastroenterology, Hepatology and Infectious Diseases, Friedrich Schiller University Jena, Germany
Department of Medicine I, University Medical Center Hamburg Eppendorf, Germany
Institute of Industrial, Environmental and Social Medicine, Medical Faculty of the Goethe University Frankfurt/Main, Germany
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (3)
Table 1. Compilation of reported cases with suspected hepatotoxicity by herbal Traditional Chinese Medicine.
Table 2. Reported causality assessment by the CIOMS (Council for International Organizations of Medical Sciences) scale in cases of assumed herbal hepatotoxicity by Traditional Chinese Medicine.
Table 3. Causality reassessment of positive reexposure test results initially reported in original publications for cases of herbalhepatotoxicity by Traditional Chinese Medicine.
Mostrar másMostrar menos
Abstract

Traditional Chinese Medicine (TCM) with its focus on herbal use became popular worldwide. Treatment was perceived as safe, with neglect of rare adverse reactions including liver injury. To compile worldwide cases of liver injury by herbal TCM, we undertook a selective literature search in the PubMed database and searched for the items Traditional Chinese Medicine, TCM, Traditional Asian Medicine, and Traditional Oriental Medicine, also combined with the terms herbal hepatotoxicity or herb induced liver injury. The search focused primarily on English-language case reports, case series, and clinical reviews. We identified reported hepatotoxicity cases in 77 relevant publications with 57 different herbs and herbal mixtures of TCM, which were further analyzed for causality by the Council for International Organizations of Medical Sciences (CIOMS) scale, positive reexposure test results, or both. Causality was established for 28/57 different herbs or herbal mixtures, Bai Xian Pi, Bo He, Ci Wu Jia, Chuan Lian Zi, Da Huang, Gan Cao, Ge Gen, Ho Shou Wu, Huang Qin, Hwang Geun Cho, Ji Gu Cao, Ji Xue Cao, Jin Bu Huan, Jue Ming Zi, Jiguja, Kudzu, Ling Yang Qing Fei Keli, Lu Cha, Rhen Shen, Ma Huang, Shou Wu Pian, Shan Chi, Shen Min, Syo Saiko To, Xiao Chai Hu Tang, Yin Chen Hao, Zexie, and Zhen Chu Cao. In conclusion, this compilation of liver injury cases establishes causality for 28/57 different TCM herbs and herbal mixtures, aiding diagnosis for physicians who care for patients with liver disease possibly related to herbal TCM.

Keywords:
Herb induced liver injury
Council for International Organizations of Medical Sciences
Herbs
Causality assessment
Re-exposure
Texto completo
Introduction

Traditional Chinese Medicine (TCM) and in particular its herbal sector is popular in China1 and many countries worldwide.24 For most traditional herbal treatments, there is insufficient rigorous scientific evidence about the efficiency of herbal TCM for their claimed indications,3 usually due to lack of research publications in English. Consequently, additional controlled clinical trials are needed to evaluate their efficacy and risk profile including scientific publications, preferentially in English.5 In Western countries, herbal TCM is considered as natural and erroneously thereby assumed to be safe, delaying recognition of possible side effects and timely treatment discontinuation. Although side effects by herbal TCM in general are rare and mostly transient upon treatment cessation, hepatic adverse reactions may be life threatening, requiring a liver transplant, or both.68

This concise article presents for the first time a comprehensive tabular compilation of all potentially hepatotoxic herbal TCMs. These are individually identified by respective references published since 1986. Additional information is provided for the names of the authors, the year of publication, and the overall number of reported cases. Other tabular compilations present results of individual causality assessments by liver specific algorithms and positive reexposure test results.

Literature Search

To collect all cases of liver injury by herbal TCM, a selective literature search in the PubMed database was performed. We used the search items Traditional Chinese Medicine, TCM, Traditional Asian Medicine, and Traditional Oriental Medicine alone and combined with the terms herbal hepatotoxicity, or herb induced liver injury.

The search was primarily focused on English-language case reports, case series, and clinical reviews, published from 1984 to 15 March, 2014. From each search, the first 25 publications being the most relevant publications were analyzed for subject matter, data quality, and overall suitability. All citations in these publications were searched for other yet unidentified case reports.

Traditional Chinese Medicine

TCM is no single entity but encompasses different practices including acupuncture, moxibustion, massage, dietary therapy, and physical exercise such as shadow boxing, with herbal medicines as the most important section.13 In Western countries, the use of the name TCM remained unchanged, in recognition of the tradition originating from ancient China. Therefore, we used the term Traditional Chinese Medicine (TCM) pragmatically as a general term since a regional differentiation would introduce unwanted selection bias effects unrelated to the herbal ingredients. TCM in this review therefore combines Traditional Asian Medicine (TAM), Traditional Oriental Medicine (TOM), Traditional Korean Medicine (TKM), and Traditional Kampo Medicine (TKM) since the principles are identical or vary little between countries. Using TCM as the generic term facilitates and focuses discussions of TCM related issues.

Compilation Of Relevant Cases

We identified 57 different herbs and herbal mixtures of TCM with potential liver injury in 77 case reports and case series (Table 1); their clinical case details were presented earlier.987 Such a detailed compilation of cases has not been published before and it may assist clinicians and practitioners evaluating patients with suspected hepatotoxicity by the use of herbal TCM. Three additional reports of hepatotoxicity cases following herbal TCM use were excluded from table 1 because details of the applied herbs were missing.8890 The figure of 57 different herbs and herbal mixtures compares with 582 medicinal herbs of the Chinese Materia Medica (CMM), which are available in China and are officially recognized and described in detail by the Chinese Pharmacopeia.91,92 If all herbs of widespread use, regional variations, and folk medicine are included, then the total increases to around 13,000 CMM preparations currently in use in China.91,93 Since our review is based on English language case reports, many more than the presently 57 different herbs and herbal mixtures of TCM with potential hepatotoxicity likely exist. This implies that reports in Chinese or other languages are not included, as they are difficult to locate, difficult to evaluate due to language barriers, and difficult to reassess. Nevertheless, a few abstracts have been included in our analysis, if provided in English and considered essential. Consequently, our analysis facilitates wide accessibility and promotes reevaluation but likely covers only a minority of the truly existing cases.

Table 1.

Compilation of reported cases with suspected hepatotoxicity by herbal Traditional Chinese Medicine.

Name with ingredients  Cases (n)  References 
An Shu LingLycopodium serratum or, rarely, Corydalis species, Panax ginseng, Pseudo ginseng, or two species of Stephania  Haller, et al., 2002 9 
Bai FangAngelica sinensis, Cyperus rotundus, Ginseng, Ligusticum wallichii, Paeonia alba, Rehmannia glutinosa  Estes, et al., 200310 
Bai Shi WanAtractylis, Carthamus tinctorius, Dalbergia odorifera, Dioscorea bulbifera, Glycyrrhiza, Lithospermum erythrorhizon, Paeonia suffruticosa, Polygonum multiflorum, Psoralea corylifolia, Salvia miltiorrhiza; Endoconcha sepiae, Ganoderma lucidum (mushroom)  Talari, et al., 201011 
Bai Xian PiDictamnus dasycarpus  Perharic-Walton/Murray, 199212 
  Kane, et al., 199513 
  Vautier/Spiller, 199514 
  Yuen, et al., 200615 
  Jang, et al., 2 00816 
  14  Kang, et al., 200817 
  Sohn, et al., 200818 
Ban Tu WanAngelica sinensis, Chaenomeles, Codonopsis pilosula, Notopterygium, Polygonum multiflorum, Rehmannia, Schisandra  Cortez, et al., 201219 
Bo HeMentha haplocalyx     
Bo Ye Qing Niu DanTinospora crispa  Sangsuwan, et al., 200420 
Bofu Tsu Sho SanAngelica, Atractylis, Cnidium, Gardenia, Ephedra, Forsythia, Glycyrrhhiza, Gypsum fibrosum, Ledebouriella, Mentha, Paeonia, Platycodon, Rheum, Schizonepeta, Scutellaria, Zingiber; Kadinum (talcum powder), sodium sulfuricum  Motoyama, et al., 200821 
Boh Gol ZheePsoralea corylifolia  Hwang, et al., 200122 
  Nam, et al., 200523 
  Cheung, et al., 200924 
Cang Er ZiXanthium sibiricum  na  Chau, 200825 
Chai HuBupleurum falcatum  28  Lee, et al., 201126 
ChasoCamellia sinensis, Cassia tora (syn. Senna), Crataegus, Chrysanthenum morifolium Ramat., Lotus, Lycium barbarum; N-nitroso-fenfluramine  27  Adachi, et al., 200327 
Chi R YunBreynia officinalis  Lin, et al., 2002;28 
  19  Lin, et al., 200329 
Chinese herbal mixtures (various)Dictamnus dasycarpus, Gentiana scabra, Hedyotis diffusa, Paeonia suffructicosa, Paris polyphylla, Rehmannia glutinosa, Smilax glabra, Sophora subprostrata;  Perharic-Walton/Murray, 199212 
Angelica sinensis, Bupleurum chinese, Dictamnus dasycarpus, Paeonia suffructiosa, Philodendron chinese, Saposhnikovia divaricata, Shisandra chinesis, Shizonepeta tenuifolia, Tribulus terrestris;  Kane, et al., 199513 
Cocculus trilobus, Dictamnus dasycarpus, Eurysolen gracilis, Glycyrrhiza, Lophatherum, Paeonia, Potentilla, Rehmannia glutinosa;  Vautier/Spiller, 199514 
Alisma plantago aquatica, Artemisia capillaris, Bupleurum, Chrysanthemum morifolium, Circuma, Gardenia jasminoidis, Gentiana scabra, Glycyrrhiza, Magnolia, Paeonia, Plantago asiatica, Saussurea lappa  Yoshida, et al., 199630 
Chuan Lian ZiMelia toosendan  Yuen, et al., 200615 
Ci Wu JiaAcanthopanax senticosus  Sohn, et al., 200817 
Da Chai Hu TangBupleurum falcatum, Ginseng, Glycyrrhiza glabra, Pinellia, Scutellaria, Zingiber officinale, Zizyphus jujuba  Kamiyama, et al., 199731 
Da HuangRheum palmatum  Yuen, et al., 200615 
Du HuoAngelica archangelica  Björnsson, et al., 201332 
Fu Fang Qing Dai WanAngelica dahurica, Isatis indigotica (Indigo naturalis)Verucci, et al., 200233 
Massa medicata fermentata (yeast), Salvia milthiorrhiza, Smilax glabra     
Gan CaoGlycyrrhiza uralensis, syn. Liquorice  Yuen, et al., 200615 
Ge GenPueraria lobata, syn. Arrowroot  Kim, et al., 200934 
Ho Shou WuPolygonum multiflorum, syn. He Shou Wu  Yuen, et al., 200615 
  Bae, et al., 201035 
Hu Bohe YouMentha pulegium, syn. Pennyroyal oil  na  Chau, 200825 
Hu ZhangPolygonum cuspidatum  na  Chau, 200825 
Huang QinScutellaria baicalensis  19  Gono, et al., 201036 
  Linnebur, et al., 201037 
  1  Yang, et al., 201238 
  Dhanasekaran, et al., 201339 
Huang Yao ZiDioscorea bulbifera  na  Chau, 200825 
Hwang Geun ChoCorydalis speciosa  Kang, et al., 200940 
15Ji Gu CaoAbrus cantoniensis  Yuen, et al., 200615 
Ji JiChloranthus serratus  na  Chau, 200825 
Ji Xue CaoCentella asiatica, syn. Gotu Kola  Jorge/Jorge, 200541 
JigujaHovenia dulcis  Sohn, et al., 200818 
  Kang, et al., 200817 
  Kim, et al., 201242 
Jin Bu HuanLycopodium serratum or, rarely, Corydalis speciesWoolf, et al., 1994 43 
Panax ginseng, Pseudo ginseng, or two species of Stephania  Horowitz, et al., 199644 
  Picciotti, et al., 199845 
  Divinsky, 200246 
  Haller, et al., 20029 
Jue Ming ZiCassia obtusifolia, syn. Senna obtusifolia  Yuen, et al., 200615 
KamishoyosanAngelica sinensis, Atractylodes racea, Bupleurum falcatum, Gardenia, Glycyrrhiza glabra, Mentha haplocalyx, Moutan, Paeonia alba, Sclerotium Poriae Cocos, Zingiber officinale  Inoe, et al., 201147 
KudzuPueraria thunbergiana  Kang, et al., 200817 
Lei Gong TengTripterygium wilfordii Hook  na  Chau, 200825 
Long Dan Xie Gan TangAcebia, Alisma, Angelica sinensis, Bupleurum, Gardenia, Gentiana, Glycyrrhiza, Plantago, Rehmannia, Scutellaria  17  Lee, et al., 201126 
Lu ChaCamellia sinensis, syn. Chinese green tea  Garcia-Moran, et al., 200448 
  Peyrin-Biroulet, et al., 200449 
  Gloro, et al., 200550 
  Javaid/Bonkovsky, 200651 
  Jimenez-Saenz, et al., 200652 
  Bonkovsky, 200653 
  Molinari, et al., 200654 
  Björnsson/Olsson, 200755 
  García-Cortés, et al., 200856 
  34  Sarma, et al., 200857 
  36  Mazzanti, et al., 200958 
  Rohde, et al., 201159 
  47  Navarro, et al., 201360 
Ma HuangEphedra sinica  Nadir, etal.199661 
  Borum, 200162 
  Estes, et al., 200310 
  Skoulidis, et al., 200563 
  Reuben, et al., 201064 
Mao Guo Tian Jie CaiHeliotropium lasiocarpum  Culvenor, et al., 198665 
OnshidoAloe, Camellia sinensis, Crataegus141  Adachi, et al., 200327 
Gynostemma pentaphyllum makino, Raphanus; N-nitroso-fenfluramine     
Qian Li GuangSenecio scandens  na  Chau, 200825 
Ren ShenPanax ginseng  Kang, et al., 200817 
Sairei ToAlisma, Atractylis, Bupleurum, Cinnamomum, Ginseng, GlycyrrhizaAiba, et al., 200766 
Pinellia, Polyporus, Poria, Scutellaria, Zingiber, Zizyphus  Tsuda, et al., 201067 
Shan ChiGynura segetum  Dai, et al., 200668 
  Chen, et al., 200769 
  Li, et al., 201070 
  52  Lin, et al., 201171 
  116  Gao, et al., 201272 
Shen Min Black cohosh, Burdock, Cayenne pepper, Ginkgo bilobaCárdenas, et al., 200673 
Horse chestnut, Piper nigrum, Polygonum multiflorum, uva ursi; biotin,     
collagen (hydrolyzed), niacin, pantothenic acid, silica (from plant sources),     
soy isoflavones, vitamin A, vitamin B6     
Shi CanTeucrium chamaedrys, syn. Germander  na  Chau, 200825 
Shi Liu PiPericarpium granati  na  Chau, 200825 
Shou Wu PianAchyranthes bidentata, Cuscuta chinensis, Eclipta prostrataBut, et al., 199674 
Ligustrum lucidum, Lonicera japonica, Morus alba, Polygonum multiflorumPark, et al., 200175 
Psoralea corylifolia, Rehmannia glutinosa, Rosa laevigata, Sesemum indicumBattinelli, et al., 200476 
Siegesbeckia orientalis  Panis, et al., 200577 
  Sohn, et al., 200818 
  Laird, et al., 200878 
  Furukawa, et al., 201079 
  Valente, et al., 201080 
  25  Jung, et al., 201181 
  Banarova, et al., 201282 
Tian Hua FenTrichosanthes kirilowii  na  Chau, 200825 
White flood Qian Ceng Ta (Huperzia serrata), Wu Zhu Yu (Evodia rutaecarpa); beet root, caffein, cocoa bean, vinpocetine (from Vinca plant); acesulfame potassium, calcium silicate, carnitine tartrate, Carno-Syn® beta-alanine, citrulline, cryptoxanthin, folic acid, gamma-aminobutyric acid (GABA), glucuronolactone, selenium, L-norvaline, L-tyrosine, lutein, malic acid, ornithine, potassium gluconate, sucralose, sugar cane, watermelon flavor, zeaxanthin  Cohen, et al., 201283 
Wu Bei ZiGalla chinensis  na  Chau, 200825 
Xi ShuCamptotheca acuminata  na  Chau, 200825 
Xiao Chai Hu TangBupleurum falcatum, Ginseng, Glycyrrhiza glabraItoh, et al., 199584 
Pinellia tuber, Scutellaria baicalensis, Zingiber officinale, Zizyphus jujuba  19  Lee, et al., 201126 
  Hsu, et al., 200685 
Yin Chen HaoArtemisia capillaris  Kang, etal.,200817 
  Sohn, et al., 200818 
ZexieAlisma orientalis  Yuen, et al., 200615 
Zhen Chu CaoPhyllanthus urinaria  Yuen, et al., 200615 

Data are retrieved from a selective literature search for published cases of herbal TCM associated with suspected hepatotoxicity. In some cases, causality for individual herbs and herbal mixtures was established using the Council for International Organizations of Medical Sciences (CIOMS) scale or its modifications, and by positive reexposure test results. For other cases, information was fragmentary and did not necessarily allow a firm causal attribution. Details are provided by the original reports referenced above and by other articles.86,87

Botanical names of herbs are provided, which were used individually or as combination partners of herbal mixtures (Table 1). These names were retrieved from the published reports and verified through an internet search. The herbs were not always further specified, because relevant data often were contradictory and insufficiently described in the publications. One TCM name may be used for various preparations in China, but not necessarily in other countries. Among these are prepared decoction pieces (known as Yin Pian), extracts or granules of the decoction pieces (known as Keli), as well as unprepared and crude material.1 Of particular importance are Proprietary Chinese Medicines (PCM) products known as Zhong Cheng Yao, which must be approved by the China FDA before marketing.1 Unapproved PCM products are regarded illegal medicines and are commonly of poor quality, shortcomings likely applying to other countries as well.

The reference list for the reports mentioned in table 1 allows information for number and period of publication. In the years 1984 to 1993, 1994 to 2003, and 2004 to 2013, there were 2, 20, and 55 publications for the respective periods. With 28 and 27 publications for 2004 to 2008 and for 2009 to 2013, the publication frequency was stable within the last decade. Hepatotoxicity by herbal TCM is reported from many countries around the world with various publications990 from China, 4; Hong Kong, 5; Taiwan, 4; Japan, 9; Korea, 10; Thailand, 1; Australia, 2; Slovakia, 1; Italy, 5; Spain, 3; France, 2; the Netherlands, 1; the United Kingdom, 4; Denmark, 1; Iceland, 2; Canada, 2; the United States, 20; and Argentina, 1.

Herbal hepatotoxicity is not limited to herbal TCM but also occurs worldwide with numerous other herbs.7,8 Among sixty different herbs or herbal mixtures with hepatotoxic potential identified in a recent study, which analyzed 185 published reports, only few were TCM herbs.7 Overt differences of hepatotoxicity between TCM herbs and non TCM herbs are lacking in clinical presentation, types of liver injury, latency period, dechallenge characteristics, and reexposure characteristics, when comparing the original publications for the present analysis (9-85) with those of the previous publications.7,8 Both groups have a similar incidence of severity, liver transplantation, and lethal outcome.

Causality Assessment

In patients with suspected herbal liver injury by TCM, the key question is the diagnostic validity. Hepatotoxicity requires strict criteria, best defined by alanine aminotransferase (ALT) and/or alkaline phosphatase (ALP) values.94,95 Its increase is converted into multiples of the upper limit of their normal range, given as N. For ALT, hepatotoxicity has been defined as increases of > 2N, > 3N or > 5N, while ALP values of > 2N are commonly considered diagnostic.96,97 Restricting only ALT increases of > 5N as diagnostic eliminates false positive cases and substantiates causality at a higher level of probability. Considering ALT > 2N as hepatotoxic will include numerous patients with nonspecific increases, with higher requirements for thorough assessment and more stringent exclusion of causes unrelated to the herb(s) under discussion. Also for low threshold N values, more diagnostic alternatives must be ruled out; missing an exclusion of a hepatotoxicity case results in overdiagnosing and overreporting with false high case numbers.96 Commonly an ALT cutoff point of 5N is used, or an ALT cutoff of 3N if the total bilirubin exceeds 2N; for ALP, 2N is considered an appropriate definition criterion.96,97 These criteria are likely fulfilled by most reports included in this review, even considering that N values are rarely mentioned, and some publications do not mention any liver values at all.985 Applying these criteria, the herbal TCM Ba Jiao Lian (Dysosma pleianthum) was not proven hepatotoxic, although this was initially assumed.86,98 Therefore, Ba Jiao Lian is not included as a hepatotoxin in this review of TCM. Valid diagnostic biomarkers in patients with suspected herbal hepatotoxicity currently are lacking,8 except for pyrrolizidine alkaloids (PAs) where quantification of protein adducts and GSH conjugates in the blood allows intake quantification.72,86 Considering these limitations and the need of early evaluation of suspicious cases, the best approach for quick assessment is the combination of clinical judgement and a liver specific causality assessment algorithm like the scale of CIOMS (Council for International Organizations of Medical Sciences), also called RUCAM (Roussel Uclaf Causality Assessment Method).94,95 This CIOMS scale has been used in cases of herbal TCM hepatotoxicity and commonly provides high quality classifications of highly probable and probable cases initially (Table 2) or after reassessment.99 In some cases, a previous CIOMS version100 or a modified CIOMS version101 was used for assessment (Table 2). Although commonly recommended,102 overall CIOMS based evaluations were done in only 18 reports (Table 2), not in the remaining 59 publications analyzed in the present review (Table 1). In the future, therefore, all suspected cases should undergo CIOMS assessment to improve case data evaluation.

Table 2.

Reported causality assessment by the CIOMS (Council for International Organizations of Medical Sciences) scale in cases of assumed herbal hepatotoxicity by Traditional Chinese Medicine.

Product name  CIOMS causality gradings  CIOMS scores  Cases (n) 
Bai Xian Pi  Probable  6-8  218 
  na  na  1417 
Bo He  Probable  6-8  115 
Chinese herbal mixtures  Probable  188,99 
  Possible  112,99 
  Excluded  -1  116,99 
Ci Wu Jia  Probable  6-8  118 
  Possible  3-5  118 
Chuan Lian Zi  Highly probable  > 8  115 
Da Huang  Highly probable  > 8  115 
Gan Cao  Probable  6-8  115 
Ge Gen  Highly probable  10  234 
Ho Shou Wu  Highly probable  > 8  115 
  Highly probable  10  135 
Huang Qin  Possible  138,99 
Ji Gu Cao  Possible  3-5  115 
Ji Xue Cao  na  na  341 
Jin Bu Huan  Probable  243,99 
  Probable  144,99 
  Possible  144,99 
Jue Ming Zi  Highly probable  > 8  115 
Juguja  Probable  142 
  Possible  3-5  118 
Kudzu  na  na  617 
Ling Yang Qing Fei Keli  Probable  6-8  115 
Lu Cha  Highly probable  149,99 
  Highly probable  255 
  Highly probable  > 8  256 
  Probable  152,99 
  Probable  255 
  Probable  153,99 
  Probable  6-8  156 
  Probable  155 
  Possible  3-5  150 
  na  na  617 
Ma Huang  Possible  161,99 
Shou Wu Pian  Highly probable  > 8  1081 
  Highly probable  > 8  179 
  Probable  6-8  1581 
  Probable  6-8  218 
  Possible  3-5  118 
Shan Chi  Highly probable  171 
  Probable  272 
  Probable  172 
  Possible  272 
Shen Min  Probable  6-8  173 
Syo Saiko To  Highly probable  184,99 
  Probable  184,99 
  Probable  284,99 
Yin Chen Hao  Probable  6-8  118 
  na  na  717 
Zexie  Highly probable  > 8  115 
Zhen Chu Cao  Possible  3-5  115 

For the listed numbers of cases, the respective publication is provided as superscript. Most listed cases were assessed by the Council for International Organizations of Medical Sciences (CIOMS) scale,94,96 single cases by an earlier CIOMS version100 or by a modified CIOMS version.101 In some original reports, CIOMS causality grading was presented without any individual CIOMS score, so the range of the scores was provided in this table rather than an accurate score number. In one publication of a case series, data of the scores were presented only as means17 and therefore classified in the table as not available, since individual scores were not provided. Abbreviation: na, not available.

Reexposure

A positive reexposure test result commonly is considered as the gold standard to verify the diagnosis of herb induced liver injury.86,99,103 Since reexposure tests are unintentional and therefore not planned in advance, these cases also have to be analyzed in retrospect. Consequently, under these circumstances case data often are of poor quality, lacking basic criteria for a positive test result. In 25 cases of suspected herbal TCM hepatotoxicity, the authors claimed a positive reexposure test (Table 3); however, in only 14 cases this result was confirmed upon reassessment, when specific and accepted criteria were applied (Table 3).86,99 In the remaining nine patients, the evaluation was either negative or uninterpretable. Intentional reexposure tests are unethical and obsolete due to high risks.

Table 3.

Causality reassessment of positive reexposure test results initially reported in original publications for cases of herbalhepatotoxicity by Traditional Chinese Medicine.

Product name  Reexposure test conditions (reassessed)  Test results (reassessed)  Cases (n) 
Chinese herbal mixtures  ALTb < 5N, ALTr ≥ 2 ALTb  Positive  213,88 
  ALTb and ALTr not available  Uninterpretable  135 
Ho Shou Wu  Not assessable  Uninterpretable  135 
Hwang Geun Cho  ALTb < 5N, ALTr ≥ 2ALTb  Positive  117 
Ji Xue Cao  ALTb < 5N, ALTr ≥ 2ALTb  Positive  141 
  ALTb not available  Uninterpretable  141 
Jin Bu Huan  ALTb < 5N, ALTr ≥ 2 ALTb  Positive  223 
  ALTb ≥ 5N, ALTr < 2 ALTb  Negative  144 
  ALTb < 5N but ALTr < 2 ALTb  Negative  144 
Lu Cha  ALTb < 5N, ALTr ≥ 2ALTb  Positive  349,52,53 
  ALTb < 5N but ALTr not available  Uninterpretable  156 
  ALTb and ALTr not available  Uninterpretable  256,57 
Ma Huang  ALTb and ALTr not available  Uninterpretable  161 
Shou Wu Pian  ALTb < 5N, ALTr ≥ 2ALTb  Positive  277,81 
Xiao Chai  ALTb < 5N, ALTr ≥ 2 ALTb  Positive  384 
Hu Tang  ALTb < 5N but ALTr < 2 ALTb  Negative  184 

For the llisted numbers of cases, the respective publications are provided as superscripts. Clinical details and laboratory valueswere obtained from the original reports, which all described a positive reexposure test result without providing specific criteria.For all 25 cases, reassessment of the reexposure test data was done applying established and strict criteria,86,99 and the reassessedtest results are presented in the table. These results showed a positive causality only in 14 cases, without firm causalityin nine cases as claimed in the original reports. Criteria for the hepatocellular type of liver injury99,103 are the ALT levels atbaseline before reexposure (ALTb), and the ALT levels during reexposure (ALTr). Response to reexposure is considered positive if ALTr ≥ 2ALTb and ALTb < 5N, with N as the upper limit of the normal value. Other combinations result in negative causality or uninterpretableresults.ALT: alanine aminotransferase. n: upper limit of normal.

Causality Verification

Among the reported cases of herbal hepatotoxicity (Table 1), causality was verified by CIOMS scale grades, positive reexposure tests, or both for 27 different herbs and herbal mixtures (Tables 2 and 3), out of a total of 57 (Table 1). These included Bai Xian Pi, Bo He, Ci Wu Jia, Chuan Lian Zi, Da Huang, Gan Cao, Ge Gen, Ho Shou Wu, Huang Qin, Hwang Geun Cho, Ji Gu Cao, Ji Xue Cao, Jin Bu Huan, Jue Ming Zi, Juguja, Kudzu, Ling Yang Qing Fei Keli, Lu Cha, Rhen Shen, Ma Huang, Shou Wu Pian, Shan Chi, Shen Min, Syo Saiko To, Xiao Chai Hu Tang, Yin Chen Hao, Zexie, and Zhen Chu Cao. Causality was also established in two unclassified Chinese herbal mixtures (Table 2), from five mixtures initially included (Table 1).

Herbal Misidentification, Contamination, and Adulteration

It is well recognized that herbal products conform only to fewer quality standards than chemical drugs.7,8,104,105 This also applies to most herbal TCM products used worldwide.94,91,106108 In China, strict regulations exist for China FDA approved herbal TCM products, ameliorating this problem.1

In the presently analyzed reports, botanical authenticity of individual herbal ingredients mostly was not published, with exceptions related to An Shu Ling,9,86 Chi R Yun (Breynia officinalis) and Yi Yi Qiu (Securinega suffruticosa),28,29,6872,86,109,110 Jin Bu Huan and Hua Nan Yuan Zhi (Polygala chinensis),43,44 Shan Qi (Gynura segetum) and Jing Tian San Qi (Sedum aizoon),6872,86,109,110 Shan Qi (Gynura segetum) and Mao Guo Tian Jie Cai (Heliotro-pium lasiocarpum),65,111,112as well as Shou Wu Pian.74 For some herbal TCM products, problems have been identified in misidentification on package insert43,44,60,106 including mistaken herb identity,28,29,44,65,6872,86,108113 and insufficient sample amounts.113

Another concern for human use is the possible contamination with dust, pollens, insects, rodents, parasites, microbes, fungi, moulds, toxins, and pesticides.107,113 Also reported was contamination with hepatotoxic seeds20 as well as heavy metals such as arsenic, mercury, and lead.86,107,113 These shortcomings are well recognized14 and require stringent controls by producers and regulatory agencies.1 Analyses for contamination were rarely done, except for the herbal mixtures Chaso and Onshido, where contamination with heavy metals like copper, lead, bismuth, cadmium, antimony, tin, mercury, and chromium was not found.27 Contaminants also were lacking in Jin Bu Huan.43,44 In other Chinese herbal mixtures, aflatoxins,12 fungi,12 heavy metals,12 and PAs were excluded,16 but insect fragments (Cryptotympane pustulata) were present in the preparations.12 The TCM Hai Piao Xiao (Endoconcha sepiae) and Ling Zhi (Ganoderma lucidum, mushroom) are listed as ingredients of Bai Shi Wan (Table 1) 11

Even (criminal) adulterations of herbal TCM products with synthetic drugs not declared as such have been published.1,25,91,106,107 Analysis for possible adulterants were rarely done and usually negative.43,44 Adulteration of the herbal TCM products Chaso and Onshido27 and other TCM products14 by the synthetic N-nitroso-fenfluramine was found,15,27 but its hepatotoxic property has not been established.27,86 N-nitroso-fenfluramine therefore is merely an adulterant that is not related to liver injury86 observed in the reported cases.15,27 Neither Chaso nor Onshido are registered by the China FDA; but were produced by Chinese manufacturers and exported to Japan until retracted from the market.27 Actually, China FDA has established analytical methods and product inspections to provide consumer safety.1 Especially for unregistered products, adulteration with chemical compounds remains a problem in China and other countries.

Non Herbal TCM

Uncertainty of and concern for hepatotoxicity exists also related to the use of non-herbal TCM elements.15,17,18,25,48,91,114118 They are commonly consumed together with herbal TCM products15,91 and occasionally even named identically.91 Known or potentially hepatotoxic non-herbal TCM elements are Bai Hua She (venom of the Chinese viper Agkistrodon acutus),15Jiang Can (dried larvae of Bombyx Batryticatus, infected by Batrytis bassiana),15Ling Yang Qing Fei (antelope horn),15 Liyu Danzhi (carp juice),114 Quan Xie (dry polypides of the scorpion Buthus martensii),15Sang Hwang (Phellinus lihnteus, mushroom),17,18 Song Rong (Agaricus blazei, Himematsutake as Japanese Kampo Medicine, mushroom),115 Wu Gong (dried polypites of the centipede Scolopendra subspinipes mutilans),15Wu Shao She (syn. Wu Xiao She, Sheng Wu Shao She, parts of the snake Zaocys dhumnades),15and Yu Dan (fish gallbladder).116118 Details of their adverse properties to date often remain unexplored for some products.

Cochrane

The Cochrane Handbook provides some general recommendations related to adverse effects, especially choosing which adverse effects to include, the types of studies, and search methods for adverse effects.119 These specifications do not necessarily apply to our short analysis, since we focused only on one single adverse effect and did not choose other adverse types. Our report also was based on single case reports or short case series, not on various types of detailed studies which actually are not available in the scientific literature for further assessment by us and others. Finally, specific search methods for hepatotoxicity cases have already been applied in this analysis, and there is no need for additional refinement.

However, the Cochrane Handbook119 was a good basis evaluating and summarizing evidence from the Cochrane Collaboration for traditional Chinese medicine therapies with focus on herbal TCM.120 Overall, 70 Cochrane systematic reviews of TCM were identified, including 42 reviews related to herbal TCM, with 22/42 herbal medicine reviews that concluded that there was not enough good quality trial evidence to make any conclusion about the efficacy of the evaluated treatment, while the remaining 20 herbal TCM reviews indicated a suggestion of benefit, which was qualified by a caveat about the poor quality and quantity of studies. Most reviews included many distinct interventions, controls, outcomes, and populations, and a large number of different comparisons were made, each with a distinct forest plot.120

Considering these uncertainties of therapeutic efficacy as summarized by the Cochrane reviews for herbal TCM120 and the hepatotoxicity risk of herbal TCM use as outlined in the present study (Table 1), the risk/benefit/ratio is clearly negative.

Limitation of the Analysis

Products of herbal TCM commonly are used as TCM dietary supplements or TCM drugs. Product variability and lack of product standardization regarding their ingredients may create uncertainty and scientific discussions. In addition, listed herbs or products might be arguable as having merely a low affinity to TCM. For many TCM mixtures, only the primary pharmacologically active the other component, called the king herb, is mentioned as ingredient,6 neglecting the other ingredients. This may cause some irritation and discussion due to incomplete product specification.

Conclusions

Liver injury was reported for 57 different TCM herbs and herbal mixtures. Causality was likely or probable for 28 out of these 57 herbal products based on the CIOMS scale, positive reexposure test results, or both, while the remaining cases often remained unassessable. Thus, further efforts are needed to enhance the quality of causality assessment for future cases of suspected herbal hepatotoxicity by TCM; an objective approach like the CIOMS scale should be applied in all cases.

Acknowledgement

The authors declare that they have no conflict on interest.

References
[1.]
Zhang L., Yan J., Liu X., Ye Z., Yang X., Meyboom R., Chan K., et al.
Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: Current status and future perspective.
J Ethnopharmacol, 140 (2012), pp. 519-525
[2.]
Tang J.L., Liu B.Y., Ma K.W..
Traditional Chinese medicine.
Lancet, 372 (2008), pp. 1938-1940
[3.]
NIH, National Center for Complementary and Alternative Medicine (NCCAM). Traditional Chinese Medicine: An Introduction. Last updated October 2013. Available at: http://nccam.nih.gov/health/whatiscam/chinesemed.htm [Accessed 7 July, 2014].
[4.]
National Institutes of Health (NIH) and LiverTox: Chinese and other Asian herbal medicines. Last updated 10 January 2013. Available at:http://livertox.nih.gov/ChineseAndOtherAsianHerbalMedicines.htm [Accessed 7 July, 2014].
[5.]
Ernst E..
Review article. Methodological aspects of Traditional Chinese Medicine (TCM).
Ann Acad Med Singapore, 35 (2006), pp. 773-774
[6.]
Bunchorntavakul C., Reddy K.R..
Review article: herbal and dietary supplement hepatotoxicity.
Aliment Pharmacol Ther, 37 (2013), pp. 3-17
[7.]
Teschke R., Wolff A., Frenzel C., Schulze J., Eickhoff A..
Herbal hepatotoxicity: A tabular compilation of reported cases.
Liver Int, 32 (2012), pp. 1543-1556
[8.]
Teschke R., Schwarzenboeck A., Eickhoff A., Frenzel C., Wolff A., Schulze J..
Clinical and causality assessment in herbal hepatotoxicity.
Expert Opin Drug Saf, 12 (2013), pp. 330-366
[9.]
Haller C.A., Dyer J.E., Ko R., Olson K.R..
Making a diagnosis of herbal-related toxic hepatitis.
West J Med, 176 (2002), pp. 39-44
[10.]
Estes J.D., Stolpman D., Olyaei A., Corless C.L., Ham J.M., Schwartz J.M., Orloff S..
High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure.
Arch Surg, 138 (2003), pp. 852-858
[11.]
Talari P, Talari G, Gundareddy V, Vemula P, Barmecha J. Acute hepatitis associated with the chinese herbal product bai shi wan. Available at:http://www.toothpicks.info/rc2/posters/2010/Internal_Medicine/Talari_P_Acute_hepatitis_associated.pdf [Accessed 7 July, 2014].
[12.]
Perharic-Walton L., Murray V..
Toxicity of traditional Chinese herbal remedies.
Lancet, 340 (1992), pp. 674
[13.]
Kane J.A., Kane S.P., Jain S..
Hepatitis induced by traditional Chinese herbs: possible toxic components.
Gut, 36 (1995), pp. 146-147
[14.]
Vautier G., Spiller R.C..
Safety of complementary medicines should be monitored.
[15.]
Yuen M.F., Tam S., Fung J., Wong D.KH., Wong B.CY., Lai C.L..
Traditional Chinese Medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study.
Aliment Pharmacol Ther, 24 (2006), pp. 1179-1186
[16.]
Jang J.S., Seo E.G., Han C., Chae H.B., Kim S.J., Lee J.D., Wang J.H..
Four cases of toxic liver injury associated with Dictamnus dasycarpus.
Korean J Hepatol, 14 (2008), pp. 206-212
[17.]
Kang S.H., Kim J.I., Jeong K.H., Ko K.H., Ko P.G., Hwang S.W., Kim E.M., et al.
Clinical characteristics of 159 cases of acute toxic hepatitis.
Korean J Hepatol, 14 (2008), pp. 483-484
[18.]
Sohn C.H., Cha M.I., Oh B.J., Yeo W.H., Lee J.H., Kim W., Lim K.S..
Liver transplantation for acute toxic hepatitis due to herbal medicines and preparations.
J Korean Soc Clin Toxicol, 6 (2008), pp. 110-116
[19.]
Cortez E, Boulger C, Bernard A. Ban Tu Wan hepatotoxicity. BMJ Case Reports 2012. DOI: 10.1136/bcr-2012-006438.
[20.]
Sangsuwan C., Udompanthurak S., Vannasaeng S., Thamlikitkul V..
Randomized controlled trial of Tinospora crispa for additional therapy in patients with type 2 diabetes mellitus.
J Med Assoc Thai, 87 (2004), pp. 543-546
[21.]
Motoyama H., Enomoto M., Yasuda T., Fujii H., Kobayashi S., Iwai S., Morikawa H., et al.
Drug-induced liver injury caused by a herbal medicine, bofu-tsu-sho-san.
Nihon Shokakibyo Gakkai Zasshi, 105 (2008), pp. 1234-1239
[22.]
Hwang S.H., Park J.A., Jang Y.S., Lee K.M., Lee D.S., Ahn B.M., Lee E.H..
Case of acute cholestatic hepatitis caused by the seeds of Psoralea-corylifolia.
Korean J Hepatol, 7 (2001), pp. 341-344
[23.]
Nam S.W., Baek J.T., Lee D.S., Kang S.B., Ahn B.M., Chung K.W..
A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia (Boh-Gol-Zhee).
Clin Toxicol, 43 (2005), pp. 589-591
[24.]
Cheung W.I., Tse M.L., Ngan T., Lin J., Lee W.K., Poon W.T., Mak T.W., et al.
Liver injury associated with the use of Fructus Psoraleae (Bol-gol-zhee or Bu-gu-zhi) and its related propriety medicine.
Clin Toxicol, 47 (2009), pp. 683-685
[25.]
Chau T.N..
Drug-induced liver injury: an update.
Hong Kong Med Diary, 13 (2008), pp. 23-26
[26.]
Lee C.H., Wang J.D., Chen P.C..
Risk of liver injury associated with Chinese herbal products containing Radix bupleuri in 639,779 patients with hepatitis B virus infection.
[27.]
Adachi M., Saito H., Kobayashi H., Horie Y., Kato S., Yoshioka M., Ishii H..
Hepatic injury in 12 patients taking the herbal loss aids Chaso and Onshido.
Ann Intern Med, 139 (2003), pp. 488-492
[28.]
Lin T.J., Tsai M.S., Chiou N.M., Deng J.F., Chiu N.Y..
Hepatotoxicity caused by Breynia officinalis.
Vet Hum Toxicol, 44 (2002), pp. 87-88
[29.]
Lin T.J., Su C.C., Lan C.K., Jiang D.D., Tsai J.L., Tsai M.S..
Acute poisonings with Breynia officinalis - an outbreak of hepatotoxicity.
J Toxicol Clin Toxicol, 41 (2003), pp. 591-594
[30.]
Yoshida E.M., McLean C.A., Cheng E.S., Blanc P.D., Somberg K.A., Ferrell L.D., Lake J.R..
Chinese herbal medicine, fulminant hepatitis, and liver transplantation.
Am J Gastroenterol, 91 (1996), pp. 2647-2648
[31.]
Kamiyama T., Nouchi T., Kojima S., Murata N., Ikeda T., Sato C..
Autoimmune hepatitis triggered by administration of an herbal medicine.
Am J Gastroenterol, 92 (1997), pp. 703-704
[32.]
Björnsson E.S., Bergmann O.M., Björnsson H.K., Kvaran R.B., Olafsson S..
Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland.
Gastroenterology, 144 (2013), pp. 1419-1425
[33.]
Verucchi G., Calza L., Attard L., Chiodo F..
Acute hepatitis induced by traditional Chinese herbs used in the treatment of psoriasis.
J Gastroenterol Hepatol, 17 (2002), pp. 1342-1343
[34.]
Kim S.Y., Yim H.J., Ahn J.H., Kim J.H., Kim J.N., Yoon I., Kim D.I., et al.
Two cases of toxic hepatitis caused by arrowroot juice.
Korean J Hepatol, 15 (2009), pp. 504-509
[35.]
Bae S.H., Kim D.H., Bae Y.S., Lee K.J., Kim D.W., Yoon J.B., Hong J.H., et al.
Toxic hepatitis associated with Polygoni multiflori.
Korean J Hepatol, 16 (2010), pp. 182-186
[36.]
Gono Y., Odaguchi H., Hayasaki T., Suzuki K., Oikawa T., Muranushi A., Akahoshi T., et al.
Clinical analysis of cases with drug-induced liver injury for Kampo medicine.
Kampo Med, 61 (2010), pp. 828-833
[37.]
Linnebur S.A., Rapacchietta O.C., Vejar M..
Hepatotoxicity associated with chinese skullcap contained in Move Free Advanced dietary supplement: two case reports and review of the literature.
Pharmacotherapy, 750 (2010), pp. 258e-262e
[38.]
Yang L., Aronsohn A., Hart J., Jensen D..
Herbal hepatotoxicity from Chinese skullcap: A case report.
World J Hepatol, 4 (2012), pp. 231-233
[39.]
Dhanasekaran R, Owens V, Sanchez W. Chinese skullcap in Move Free arthritis supplement causes drug induced liver injury and pulmonary infiltrates. Case Reports Hepatol 2013. Article ID 965092. DOI: org/10.1155/2013/965092.
[40.]
Kang H.S., Choi H.S., Yun T.J., Lee K.G., Seo Y.S., Yeon J.E., Byun K.S., et al.
A case of acute cholestatic hepatitis induced by Corydalis speciosa Max.
Korean J Hepatol, 15 (2009), pp. 517-523
[41.]
Jorge O.A., Jorge A.D..
Hepatotoxicity associated with the ingestion of Centella asiatica.
Rev Esp Enferm Dig, 97 (2005), pp. 115-124
[42.]
Kim Y.J., Ryu S.L., Shim J.W., Kim D.S., Shim J.Y., Park M.S., Jung H.L..
A pediatric case of toxic hepatitis induced by Hovenia dulcis.
Pediatr Gastroenterol Hepatol Nutr, 15 (2012), pp. 111-116
[43.]
Woolf G.M., Petrovic L.M., Rojter S.E., Wainwright S., Villamil F.G., Katkov W.N., Michieletti P., et al.
Acute hepatitis associated with the Chinese herbal product Jin Bu Huan.
Ann Intern Med, 121 (1994), pp. 729-735
[44.]
Horowitz R.S., Feldhaus K., Dart R.C., Stermitz F.R., Beck J.J..
The clinical spectrum of Jin Bu Huan toxicity.
Arch Intern Med, 156 (1996), pp. 899-903
[45.]
Picciotti A., Campo N., Brizzolara R., Giusto R., Guido G., Sinelli N., Lapertosa G., et al.
Chronic hepatitis induced by Jin Bu Huan.
J Hepatol, 28 (1998), pp. 165-167
[46.]
Divinsky M..
Case report: Jin Bu Huan - not so benign herbal medicine.
Can Fam Physician, 48 (2002), pp. 1640-1642
[47.]
Inoue H., Yamazaki S., Shimizu M., Uozki H., Goto T., Ohnishi S., Koike K..
Liver injury induced by the Japanese herbal drug kamishoyosan.
Gastroenterol Hepatol, 7 (2011), pp. 692-695
[48.]
Garcia-Moran S., Saez-Royuela F., Gento E., Lopez Morante A., Arias L..
Acute hepatitis associated with Camellia tea and Orthosiphon stamineus ingestion.
Gastroenterol Hepatol, 27 (2004), pp. 559-560
[49.]
Peyrin-Biroulet L., Petitpain N., Kalt P., Ancel D., Petit-Laurent F., Trechot P., Barraud H., et al.
Probable hepatotoxicity from epigallocatecol gallate used for phytotherapy.
Gastroenterol Clin Biol, 28 (2004), pp. 404-406
[50.]
Gloro R., Hourmand-Ollivier I., Mosquet B., Mosquet L., Rousselot P., Salamé E., Piquet M.A., et al.
Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea.
Eur J Gastroenterol Hepatol, 17 (2005), pp. 1135-1137
[51.]
Javaid A., Bonkovsky H.L..
Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern.
J Hepatol, 45 (2006), pp. 334-335
[52.]
Jimenez-Saenz M., Martinez-Sanchez M del C..
Acute hepatitis associated with the use of green tea infusions.
J Hepatol, 44 (2006), pp. 616-617
[53.]
Bonkovsky H.L..
Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis).
Ann Intern Med, 144 (2006), pp. 68-71
[54.]
Molinari M., Watt K.D., Kruszyna T., Nelson R., Walsh M., Huang W.Y., Nashan B., et al.
Acute liver failure induced by green tea extracts: case reports and review of the literature.
Liver Transpl, 12 (2006), pp. 1892-1895
[55.]
Björnsson E., Olsson R..
Serious adverse liver reactions associated with herbal weight loss supplements.
J Hepatol, 47 (2007), pp. 295-297
[56.]
García-Cortés M., Borraz Y., Lucena M.I., Peláez G., Salmerón J., Diago M., Martínez-Sierra M.C., et al.
Liver injury induced by “natural remedies”: an analysis of cases submitted to the Spanish Liver Toxicity Registry.
Rev Esp Enferm Dig, 100 (2008), pp. 688-695
[57.]
Sarma D.N., Barrett M.L., Chavez M.L., Gardiner P., Ko R., Mahady G.B., Marles R.J., et al.
Safety of green tea extract: a systematic review by the US Pharmacopeia.
[58.]
Mazzanti G., Menniti-Ippolito F., Moro P.A., Cassetti F., Raschetti R., Santuccio C., Mastrangelo S..
Hepatotoxicity from green tea: a review of the literature and two unpublished cases.
Eur J Clin Pharmacol, 65 (2009), pp. 331-341
[59.]
Rohde J., Jacobsen C., Kromann-Andersen H..
Toxic hepatitis triggered by green tea.
Ugeskr Laeger, 173 (2011), pp. 205-206
[60.]
Navarro V.J., Bonkovsky H.L., Hwang S.I., Vega M., Barnhart H., Serrano J..
Catechins in dietary supplements and hepatotoxicity.
Dig Dis Sci, 58 (2013), pp. 2682-2690
[61.]
Nadir A., Agrawal S., King P.D., Marshall J.B..
Acute hepatitis associated with the use of a Chinese herbal product, mahuang.
Am J Gastroenterol, 91 (1996), pp. 1436-1438
[62.]
Borum M.L..
Fulminant exacerbation of autoimmune hepatitis after the use of Ma Huang.
Am J Gastroenterol, 96 (2001), pp. 1654-1655
[63.]
Skoulidis F., Alexander G.J., Davies S.E..
Ma huang associated acute liver failure requiring liver transplantation.
Eur J Gastroenterol Hepatol, 17 (2005), pp. 581-584
[64.]
Reuben A., Koch D.G., Lee W.M., and the Acute Liver Failure Study Group.
Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study.
Hepatology, 52 (2010), pp. 2065-2076
[65.]
Culvenor C.CJ., Edgar J.A., Smith L.W., Kumana C.R., Lin H.J..
Heliotropium lasiocarpum Fisch and Mey identified as cause of veno-occlusive disease due to herbal tea.
Lancet, 1 (1986), pp. 978
[66.]
Aiba T., Takahashi T., Suzuki K., Okoshi S., Nomoto M., Uno K., Aoyagi Y..
Liver injury induced by a Japanese herbal medicine, sairei-to (TJ-114, Bupleurum and Hoelen combination, Chai-Ling-Tang).
J Gastroenterol Hepatol, 22 (2007), pp. 762-763
[67.]
Tsuda T., Yashiro S., Gamo Y., Watanabe K., Hoshino T., Oikawa T., Hanawa T..
Discrepancy between clinical course and drug-induced lymphocyte stimulation tests in a case of saireito-induced liver injury accompanied by Sjögren syndrome.
J Altern Complement Med, 16 (2010), pp. 501-505
[68.]
Dai H.F., Gao Y., Yang M., Yu C.H., Gu Z.Y., Chen W.X..
Hepatic veno-occlusive disease induced by Gymura segetum: report of two cases.
Hepatobiliary Pancreat Dis Int, 5 (2006), pp. 406-408
[69.]
Chen M.Y., Cai J.T., Du Q..
Hepatic veno-occlusive disease associated with the use of Gynura segetum.
Eur J Intern Med, 18 (2007), pp. 609
[70.]
Li C., Liang X.S., Li C.Z..
Sinusoidal obstruction syndrome associated with the ingestion of gynura root.
Clin Toxicol, 48 (2010), pp. 962-964
[71.]
Lin G., Wang J.Y., Li N., Li M., Gao H., Ji Y., Zhang F., et al.
Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.
J Hepatol, 54 (2011), pp. 666-673
[72.]
Gao H., Li N., Wang J.Y., Zhang S.C., Lin G..
Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.
[73.]
Cárdenas A., Restrepo J.C., Sierra F., Correa G..
Acute hepatitis due to shen-min: a herbal product derived from Polygonum multiflorum.
J Clin Gastroenterol, 40 (2006), pp. 629-632
[74.]
But P.PH., Tomlinson B., Lee K.L..
Hepatitis related to the Chinese medicine Shou-wu-pian manufactured from Polygonum multiflorum.
Vet Hum Toxicol, 38 (1996), pp. 280-282
[75.]
Park G.JH., Mann S.P., Ngu M.C..
Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum.
J Gastroenterol Hepatol, 16 (2001), pp. 115-117
[76.]
Battinelli L., Daniele C., Mazzanti G., Mastroianni C.M., Lichtner M., Coletta S., Costantini S..
New case of acute hepatitis following the consumption of Shou Wu Pian, a Chinese herbal product derived from Polygonum multiflorum.
Ann Intern Med, 140 (2004), pp. 587-588
[77.]
Panis B., Wong D.R., Hooymans P.M., De Smet P.AGM., Rosias P.R..
Recurrent toxic hepatitis in a Caucasian girl related to the use of Shou-Wu-Pian, a Chinese herbal preparation.
J Pediat Gastroenterol Nutr, 41 (2005), pp. 256-258
[78.]
Laird A.R., Ramchandani N., deGoma E.M., Avula B., Khan I.A., Gesundheit N..
Acute hepatitis associated with the use of an herbal supplement (Polygonum multiflorum) mimicking iron-overload syndrome.
Clin Gastroenterol, 42 (2008), pp. 861-862
[79.]
Furukawa M., Kasajima S., Nakamura Y., Shouzushima M., Nagatani N., Takinishi A., Taguchi A., et al.
Toxic hepatitis induced by Show-Wu-Pian, a Chinese herbal preparation.
Inter Med, 49 (2010), pp. 1537-1540
[80.]
Valente G., Sanges M., Campione S., Bellevicine C., De Franchis G., Sollazzo R., Matera D., et al.
Herbal hepatotoxicity: a case of difficult interpretation.
Eur Rev Med Pharmacol Sci, 14 (2010), pp. 865-870
[81.]
Jung K.A., Min H.J., Yoo S.S., Kim H.J., Choi S.N., Ha C.Y., Kim H.J., et al.
Drug-induced liver injury: Twenty five cases of acute hepatitis following ingestion of Polygonum multiflorum Thun.
Gut Liver, 5 (2011), pp. 493-499
[82.]
Banarova A., Koller T., Payer J..
Toxic hepatitis induced by Polygonum multiflorum.
Vnitr Lek, 58 (2012), pp. 958-962
[83.]
Cohen SM, Heywood E, Pillai A, Ahn J. Hepatotoxicity associated with the use of White Flood, a nutritional supplement. Practical Gastroenterology 2012; October issue: 45-8.
[84.]
Itoh S., Marutani K., Nishijima T., Matsuo S., Itabashi M..
Liver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang).
Dig Dis Sci, 40 (1995), pp. 1845-1848
[85.]
Hsu L.M., Huang Y.S., Tsay S.H., Chang F.Y., Lee S.D..
Acute hepatitis induced by Chinese hepatoprotective herb xiaochai-hu-tang.
J Chin Med Assoc, 69 (2006), pp. 86-88
[86.]
Teschke R..
Traditional Chinese Medicine induced liver injury.
J Clin Translat Hepatol, 2 (2014), pp. 80-94
[87.]
Teschke R., Wolff A., Frenzel C., Schulze J..
Review article: herbal hepatotoxicity - an update on traditional Chinese medicine preparations.
Aliment Pharmacol Ther, 40 (2014), pp. 32-50
[88.]
Davies E.G., Pollock I., Steel H.M..
Chinese herbs for eczema.
Lancet, 336 (1990), pp. 117
[89.]
Graham-Brown R..
Toxicity of Chinese herbal remedies.
Lancet, 340 (1992), pp. 673
[90.]
Sanders D., Kennedy N., McKendrick M.W..
Monitoring the safety of herbal remedies: Herbal remedies have a heterogeneous nature.
Br Med J, 311 (1995), pp. 1569
[91.]
Shaw D..
Toxicological risks of Chinese herbs.
Planta Med, 76 (2010), pp. 2012-2018
[92.]
Pharmacopoeia of the People’s Republic of China, Vol. 1. Beijing: Peoples Medical Publishing House; 2005.
[93.]
Chan K..
Chinese medicinal materials and their interface with Western medical concepts.
J Ethnopharmacol, 96 (2005), pp. 1-18
[94.]
Danan G., Bénichou C..
Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.
J Clin Epidemiol, 46 (1993), pp. 1323-1330
[95.]
Teschke R., Frenzel C., Schulze J., Eickhoff A..
Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods.
World J Gastroenterol, 19 (2013), pp. 2864-2882
[96.]
Teschke R., Wolff A., Frenzel C., Schwarzenboeck A., Schulze J., Eickhoff A..
Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment.
World J Hepatol, 6 (2014), pp. 17-32
[97.]
Aithal G.P., Watkins P.B., Andrade R.J., Larrey D., Molokhia M., Takikawa H., Hunt C.M., et al.
Case definition and phenotype standardization in drug-induced liver injury.
Clin Pharmacol Ther, 89 (2011), pp. 806-815
[98.]
National Institutes of Health (NIH) and LiverTox: Drug record. Ba Jiao Lian (Dysosma pleianthum). Last updated 10 September 2013. Available at:http://livertox.nih.gov/BaJiaoLian.htm [Accessed 7 May, 2014].
[99.]
Teschke R., Genthner A., Wolff A., Frenzel C., Schulze J., Eickhoff A..
Herbal hepatotoxicity: Analysis of cases with initially reported positive reexposure tests.
Dig Liv Dis, 46 (2014), pp. 264-269
[100.]
Bénichou C..
Criteria of drug-induced liver disorders. Report of an international consensus meeting.
J Hepatol, 11 (1990), pp. 272-276
[101.]
Takikawa H..
A proposal of the diagnostic scale of drug-induced liver injury.
Hepatology Res, 32 (2005), pp. 250-251
[102.]
Chau T.N., Cheung W.I., Ngan T., Lin J., Lee K.WS., Poon W.T., Leung V.KS., and the Hong Kong Herb-Induced Liver Injury Network (HK-HILIN), et al.
Causality assessment of herb-induced liver injury using multidisciplinary approach and the Roussel Uclaf Causality Assessment Method (RUCAM).
Clin Toxicol, 49 (2011), pp. 34-39
[103.]
Teschke R., Frenzel C., Schulze J., Schwarzenboeck A., Eickhoff A..
Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests.
World J Hepatol, 5 (2013), pp. 353-363
[104.]
Teschke R., Frenzel C., Glass X., Schulze J., Eickhoff A..
Herbal hepatotoxicity: A critical review.
Br J Clin Pharmacol, 75 (2013), pp. 630-636
[105.]
Teschke R., Lebot V..
Proposal for a Kava Quality Standardization Code.
Food Chem Toxicol, 49 (2011), pp. 2503-2516
[106.]
Ernst E..
Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review.
J Intern Med, 252 (2002), pp. 107-113
[107.]
Posadzki P., Watson L., Ernst E..
Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews.
Eur J Clin Pharmacol, 69 (2013), pp. 295-307
[108.]
National Institutes of Health (NIH) and LiverTox: Drug record. Chi R Yun (Breynia officinalis). Last updated 25 October 2013. Available at:http://livertox.nih.gov/ChiRYun.htm [Accessed 7 July, 2014].
[109.]
Wu G.L., Yu G.Y., Chen J..
Clinical analysis of hepatic venoocclusive disease induced by Sedum aizoon.
Zhongguo Zhong Yao Za Zhi, 33 (2008), pp. 2402-2404
[110.]
Wang J.Y., Gao H..
Tusanqi and hepatic sinusoidal obstruction syndrome.
Dig Dis, 15 (2014), pp. 105-107
[111.]
Kumana C.R., Ng M., Lin H.J., Ko W., Wu P.C., Todd D..
Herbal tea induced hepatic veno-occlusive disease: quantification of toxic alkaloid exposure in adults.
Gut, 26 (1985), pp. 101-104
[112.]
Kumana C.R., Ng M., Lin H.J., Ko W., Wu P.C., Todd D..
Hepatic veno-occlusive disease due to toxic alkaloid in herbal tea.
Lancet, II (1983), pp. 1360-1361
[113.]
Ko R.J..
Adulterants in Asian patent medicines.
N Engl J Med, 339 (1998), pp. 847
[114.]
Son H.S., Kim G.S., Lee S.W., Kang S.B., Back J.T., Nam S.W., Lee D.S., et al.
Toxic hepatitis associated with carp juice ingestion.
Korean J Hepatol, 12 (2006), pp. 103-106
[115.]
Mukai H., Watanabe T., Ando M., Katsumata N..
An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients.
Jpn J Clin Oncol, 36 (2006), pp. 808-810
[116.]
Chan D.WS., Yeung C.K., Chan M.K..
Acute renal failure after eating raw fish gall bladder.
BMJ, 295 (1985), pp. 897
[117.]
Xuan B.HN., Thi T.XN., Nguyen S.T., Goldfarb D.S., Stokes M.B., Rabenou R.A..
Ichthyotoxic ARF after fish gallbladder ingestion: a large case series from Vietnam.
Am J Kidney Dis, 41 (2003), pp. 220-224
[118.]
Kung S.W., Chan Y.C., Tse M.L., Lau F.L., Chau T.L., Tam M.KP..
Acute renal failure and hepatitis following ingestion of carp gallbladder.
Clin Toxicol, 46 (2008), pp. 753-757
[119.]
Higgins JPT, Green S (eds.). Cochrane Handbook for Systematic Reviews of Interventions (Cochrane Book). Wiley Blackwell, Chiester, West Sussex, England; 2008.
[120.]
Manheimer E., Wieland S., Kimborough E., Cheng K., Berman B.M..
Evidence from the Cochrane Collaboration for traditional Chinese medicine therapies.
J Alternat Complement Med, 15 (2009), pp. 1001-1004
Copyright © 2015. Fundación Clínica Médica Sur, A.C.
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos